Is this the end for hopes of an early breakthrough in the race to find a coronavirus drug?
The halt in development of the University of Oxford’s Covid-19 vaccine due to a possible adverse reaction in a trial participant has triggered fears of a delay in finding a solution to coronavirus restrictions.
A spokesman for AstraZeneca, the company working with the academic team to produce the vaccine, said the voluntary pause is “routine”.
Related: Oxford University Covid vaccine trial put on hold due to adverse reaction in participant
Related: Why are Australian church leaders opposing the Oxford coronavirus vaccine?
Related: Covid-19: ‘possible’ Oxford vaccine data will be put before regulators this year
